
Ricker Pharmaceuticals Pvt Ltd
About Ricker Pharmaceuticals Pvt Ltd
Data last updated:
Ricker Pharmaceuticals Pvt Ltd is a private limited company based in Kalyani, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 June 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB1986PTC040787. Its GSTIN is 19AABCR2738N1ZX (West Bengal). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹23.44 Lakh. It is led by directors Narendra Kumar Bose (Managing Director) and Jhuma Bose.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 9/7(S) Kalyani, West Bengal, India – 741235.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.99 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹41.34 Lakh (net margin 8.3%) and EBITDA of ₹48.93 Lakh (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹71.37 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ricker Pharmaceuticals Pvt Ltd's registered office is in Kalyani, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 9/7(S) Kalyani, West Bengal, India – 741235
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ricker Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ricker Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ricker Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Ricker Pharmaceuticals Pvt Ltd
FY 2025 filings availableRicker Pharmaceuticals Pvt Ltd reported revenue of ₹4.99 Cr (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 1% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 8.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ricker Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Ricker Pharmaceuticals Pvt Ltd
Ricker Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jhuma Bose | Director | 22 May 1989 | 37 Years 5 Months | Current |
| Narendra Kumar Bose | Managing Director | 22 May 1989 | 37 Years 5 Months | Current |
Auditor
Ricker Pharmaceuticals Pvt Ltd is audited by C DAS & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C DAS & CO | FY 2021 | 307167E |
Shareholding
The shareholding of Ricker Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ricker Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 May 2006 | 90345592 | United Bank of India | ₹71.37 Lakh | Open |
To see the full charge records of Ricker Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 1 View all charges
Legal cases
Ricker Pharmaceuticals Pvt Ltd has 2 court cases on record: 2 filed by Ricker Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Company petition | Filed by the company against New Indian Glass Works (Cal) Ltd | Disposed |
| High Court | Company petition | Filed by the company against an individual | Disposed |
To see the full case history of Ricker Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ricker Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ricker Pharmaceuticals Pvt Ltd has a workforce of 40 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Ricker Pharmaceuticals has 5 GST registrations: 3 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCR2738N1ZX | West Bengal | Active | 01 Jul 2017 |
| 18AABCR2738N4ZW | Assam | Active | 01 Jul 2017 |
| 20AABCR2738N1ZE | Jharkhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ricker Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Ricker Pharmaceuticals Pvt Ltd has 2 board changes on record since 1989: 2 appointments. The latest: Jhuma Bose was appointed as Director on 22 May 1989.
Frequently asked questions
Ricker Pharmaceuticals is an active private limited company based in Kalyani, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 June 1986 (40+ years old) and is registered under CIN U24239WB1986PTC040787.
Ricker Pharmaceuticals has 2 current directors:
- Narendra Kumar Bose - Managing Director
- Jhuma Bose - Director
The latest financial statements of Ricker Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ricker Pharmaceuticals is 19AABCR2738N1ZX, registered in West Bengal. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 18AABCR2738N4ZW (Assam), 20AABCR2738N1ZE (Jharkhand).
The CIN (Corporate Identification Number) of Ricker Pharmaceuticals is U24239WB1986PTC040787. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ricker Pharmaceuticals has 2 court cases on record: 2 filed by the company.
Ricker Pharmaceuticals was incorporated on 10 June 1986, making it 40+ years old. It is registered with the Registrar of Companies, Kolkata.
Jhuma Bose was appointed as Director on 22 May 1989. Narendra Kumar Bose was appointed as Managing Director on 22 May 1989.
The registered office of Ricker Pharmaceuticals is at A – 97S Kalyani, West Bengal, India – 741235.
Ricker Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

